QuikReader

QuikReader

  • Latest
  • Top stories
  • Business
  • Tech
  • World
  • Politics
  • Sports
  • Lifestyle
  • Health
  • Science
  • Entertainment
  • More
    • Sources
Sign in

Latest in Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short

Sort by
1,403 items
  • No. 19 UConn falls short in 76-72 loss to Xavier

    No. 19 UConn falls short in 76-72 loss to Xavier

    Dailyn Swain and Zach Freemantle each scored 15 points to help Xavier defeat No. 19 UConn 76-72 on Saturday night.
    Yahoo Sports - Jan. 26

  • S.C. earns 'necessary' win, hands LSU first loss

    Joyce Edwards scored 14 points and Sania Feagin added 12 points and seven rebounds, and No. 2 South Carolina beat fifth-ranked LSU 66-56 on Friday night to end the Tigers' undefeated season.
    ESPN - Jan. 25

  • My wife and I are falling short of our $7,000-a-month goal for retirement income. Is it time to sell our rental properties?

    ‘We have $3.5 million worth of rental property carrying about $1.75 million in debt.”
    MarketWatch - Jan. 25
  • Short-handed 76ers beat Cavaliers 132-129 to end 7-game losing streak

    Short-handed 76ers beat Cavaliers 132-129 to end 7-game losing streak

    Paul George scored 30 points, Tyrese Maxey had 29 and the short-handed Philadelphia 76ers beat the Cleveland Cavaliers 132-129 on Friday night to end a seven-game losing streak
    ABC News - Jan. 24

  • Why Boeing’s stock isn’t tumbling, even after an ‘eye-watering’ loss warning

    The size of the loss Boeing warned of may have been unexpected, but it wasn’t a shock to Wall Street.
    MarketWatch - Jan. 24

  • Novo Nordisk shares pop on early-stage weight loss drug trial results

    The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
    CNBC - Jan. 24
  • Hair loss drug finasteride 'biggest mistake of my life'

    Hair loss drug finasteride 'biggest mistake of my life'

    Some online sites prescribe a potentially risky hair loss drug without consistent safety checks, BBC finds.
    BBC News - Jan. 24

  • American Airlines shares tumble as outlook falls short

    American forecast a wider than expected loss for the first quarter, sending shares lower.
    CNBC - Jan. 23

  • Despite acclaim, 'Dune: Part Two' falls short of 'Part One' in Oscar nominations

    'Part Two' of Denis Villeneuve's adaptation of Frank Herbert's sci-fi novel added to 'Part One's' Oscar nominations haul on Thursday, but did not duplicate the first film's success.
    Los Angeles Times - Jan. 23

  • Travelers withstands higher catastrophe losses as underwriting fuels earnings beat

    Travelers Cos. executives confirm the Los Angeles wildfires will have a material impact on the insurer’s first-quarter earnings but say it’s too soon to specify the costs.
    MarketWatch - Jan. 22

  • Procter & Gamble earnings beat estimates as shoppers buy more household staples

    Procter & Gamble beat quarterly earnings and revenue estimates and also reiterated its fiscal 2025 forecast.
    CNBC - Jan. 22

  • P&G didn’t raise prices for first time in 6 years, and Q2 earnings still beat

    P&G’s stock powers up as profit and revenue rise above expectations, and the full-year outlook was affirmed.
    MarketWatch - Jan. 22
  • 40 Years Ago, Steve Jobs Said There’s 1 Simple Habit That Separates High Performers From Those Who Fall Short

    40 Years Ago, Steve Jobs Said There’s 1 Simple Habit That Separates High Performers From Those Who Fall Short

    A brilliant Steve Jobs leadership lesson as effective today as it was in 1985.
    Inc. - Jan. 22
  • Baseball Hall of Fame: Ichiro Suzuki falls 1 vote short of unanimous election, joins CC Sabathia, Billy Wagner in 2025 class

    Baseball Hall of Fame: Ichiro Suzuki falls 1 vote short of unanimous election, joins CC Sabathia, Billy Wagner in 2025 class

    Ichiro, CC and Billy the Kid are headed to Cooperstown.
    Yahoo Sports - Jan. 21

  • Irish loss 'falls on my shoulders,' Freeman says

    Following a 34-23 loss to Ohio State in Monday's College Football Playoff title game, Notre Dame coach Marcus Freeman told reporters, "We can't make mistakes. It falls on my shoulders. And as the ...
    ESPN - Jan. 21
  • Weight-loss jabs linked to reduced risk of 42 conditions including dementia

    Weight-loss jabs linked to reduced risk of 42 conditions including dementia

    Psychotic disorders also among conditions found less likely when people with diabetes took medications found in jabs. People with diabetes taking medications found in weight-loss jabs have a ...
    The Guardian - Jan. 20
  • Weight-loss drugs may boost health in many ways, say researchers

    Weight-loss drugs may boost health in many ways, say researchers

    New weight-loss drugs have broad health benefits but also come with risks, researchers warn.
    BBC News - Jan. 20
  • Svitolina surges on but watches husband Monfils fall short as ageing body falters

    Svitolina surges on but watches husband Monfils fall short as ageing body falters

    Supporting a spouse courtside is deemed more stressful than playing with mixed emotions for tennis couple. In the aftermath of a strong comeback win that moved her into a grand slam quarter-final ...
    The Guardian - Jan. 20
  • TikTok Engineered Its Shutdown to Get Saved. But Trump’s Solution May Fall Short

    TikTok Engineered Its Shutdown to Get Saved. But Trump’s Solution May Fall Short

    President-elect Donald J. Trump’s idea, a 50-50 “joint venture” between the existing Chinese owner and some kind of American entity, was more politics than substance.
    The New York Times - Jan. 20

  • Nets bounce back after historic loss but fall short to Lakers, 102-101

    Austin Reaves scored a career-high 38 points, LeBron James had 29 and the Los Angeles Lakers held on to beat the Brooklyn Nets 102-101 on Friday night.
    Yahoo Sports - Jan. 18

  • White House says popular weight-loss drug Ozempic subject to Medicare talks

    Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.
    MarketWatch - Jan. 17
  • Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations

    Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations

    The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.
    NBC News - Jan. 17
  • Fearnley falls short against second seed Zverev

    Fearnley falls short against second seed Zverev

    Jacob Fearnley sees his encouraging Australian Open run come to an end against Alexander Zverev in the third round.
    BBC News - Jan. 17
  • Medicare to Negotiate Lower Prices for Weight-Loss Drugs

    Medicare to Negotiate Lower Prices for Weight-Loss Drugs

    The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
    The New York Times - Jan. 17
  • Biden administration falls short on finalizing sage-grouse protections

    Biden administration falls short on finalizing sage-grouse protections

    The Biden administration took steps Thursday to safeguard an iconic bird species of the Western United States — but did so in only two out of the 10 states where such protections were anticipated. ...
    The Hill - Jan. 16

  • Wells Fargo shares jump after earnings beat, strong 2025 guidance

    The lender expects 2025 net interest income, a key measure of what a bank makes on lending, to be 1% to 3% higher than 2024's number of $47.7 billion.
    CNBC - Jan. 15

  • Eli Lilly CEO expects new weight loss pill to be approved next year

    Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.
    CNBC - Jan. 13

  • Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill

    Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
    CNBC - Jan. 13
  • 'I feel blessed to get weight-loss jab' - but can the NHS afford it for all?

    'I feel blessed to get weight-loss jab' - but can the NHS afford it for all?

    We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.
    BBC News - Jan. 13
  • Marc-Andre Fleury makes 36 saves as the short-handed Wild beat the Sharks 3-1

    Marc-Andre Fleury makes 36 saves as the short-handed Wild beat the Sharks 3-1

    Marc-Andre Fleury made 36 saves, Marco Rossi and Matt Boldy scored, and the short-handed Minnesota Wild beat the San Jose Sharks 3-1
    ABC News - Jan. 12
  • What we learned as short-handed Warriors fall to red-hot Pacers

    What we learned as short-handed Warriors fall to red-hot Pacers

    Pat Spencer and Buddy Hield combined to score 34 points, but it wasn't enough as the short-handed Golden State Warriors ran out of gas against the Indiana Pacers on Friday night.
    Yahoo Sports - Jan. 11

  • Walgreens shares soar 27% on big earnings beat, as drugstore chain cuts costs

    Walgreens maintained its fiscal 2025 adjusted earnings guidance, but did not include a sales outlook in its release.
    CNBC - Jan. 10

  • High cost of weight loss drugs drives employers to require nutrition counseling, in boost for startups

    Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.
    CNBC - Jan. 10

  • Power Rankings: How far does Tennessee fall after historic loss?

    How do Florida's and Tennessee's fortunes change after the Gators' dominant showing?
    ESPN - Jan. 9

  • Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says

    It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.
    CNBC - Jan. 9
  • Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?

    Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?

    Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.
    NBC News - Jan. 9

  • Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly

    Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.
    MarketWatch - Jan. 9

  • As Art Sales Fall, Christie’s and Sotheby’s Pivot to Luxury

    With both supply and demand for big-ticket art in a slump, Sotheby’s and Christie’s are making major bets on selling handbags, classic cars and niche experiences.
    The New York Times - Jan. 9
  • Smith dumps Diageo stake over impact of weight-loss drugs on alcohol demand

    Smith dumps Diageo stake over impact of weight-loss drugs on alcohol demand

    Veteran stockpicker sells shares in spirits brand because drinks sector is being ‘impacted negatively’
    Financial Times - Jan. 9

  • Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise

    Eli Lilly has been one of the worst-performing Club stocks over the past six months.
    CNBC - Jan. 8
  • «
  • 1
  • 2
  • 3
  • »
  Follow topic
Topics
  • Eli Lilly Beats
  • Lilly Beats Earnings
  • Beats Earnings Even
  • Earnings Even Weight
  • Even Weight Loss
© 2025 QuikReader - About - Terms - Privacy